Inventor
ORENGO JAMIE
US9 patents
Patents
9 patentsUS9079948B2Jul 14, 2015
Human antibodies to Fel d1 and methods of use thereof
REGENERON PHARMA83 citations98
US9637535B2May 2, 2017
IL-33 antagonists and uses thereof
REGENERON PHARMA36 citations97
US11174305B2Nov 16, 2021
Human antibodies to Fel d1 and methods of use thereof
REGENERON PHARMA4 citations83
US10047153B2Aug 14, 2018
Human antibodies to Fel d1 and methods of use thereof
REGENERON PHARMA6 citations83
US10935554B2Mar 2, 2021
Diagnostic tests and methods for assessing safety, efficacy or outcome of allergen-specific immunotherapy (SIT)
REGENERON PHARMA3 citations72
US10047152B2Aug 14, 2018
Human antibodies to fel D1 and methods of use thereof
REGENERON PHARMA2 citations72
US9475869B2Oct 25, 2016
Human antibodies to fel d1 and methods of use thereof
REGENERON PHARMA3 citations72
US12252530B2Mar 18, 2025
Human antibodies to Fel d1 and methods of use thereof
REGENERON PHARMA0 citations62
US11964016B2Apr 23, 2024
Combination of IL-4/IL-13 pathway inhibitors and plasma cell ablation for treating allergy
REGENERON PHARMA1 citations56